The Artificial Intelligence & Cancer Network Association is a nonprofit organization established under the French Law of 1901, bringing together public and private sector stakeholders committed to the development of AI in oncology.
Longitudinal follow-up of patients with inoperable stage III non-small cell lung cancer treated with durvalumab, via the National Cancer Institute’s Cancer Data Platform
